Cartridges for immunoassay tests and methods of using the same
US-11879901-B2 · Jan 23, 2024 · US
US9714941B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9714941-B2 |
| Application number | US-18391608-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 31, 2008 |
| Priority date | Jul 31, 2007 |
| Publication date | Jul 25, 2017 |
| Grant date | Jul 25, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a bio-sensing nanodevice comprising: a stabilized biologically-derived G-protein coupled receptor—the olfactory receptor—on a support, a real time receptor-ligand binding detection method, an odorant delivery system and an odorant recognition program. The biologically-derived G-protein coupled receptor can be stabilized on nanotechnology using surfactant peptide. The said nanodevice provides a greater surface area for better precision and sensitivity to odorant detection. The invention further provides a microfluidic chip containing a stabilized biologically-derived G-protein coupled receptor—the olfactory receptor—immobilized on a support, and arranged in at least two dimensional microarray system. The invention also provides a method of delivering odorant comprising the step of manipulating the bubbles in complex microfluidic networks wherein the bubbles travel in a microfluidic channel carrying a variety of gas samples to a precise location on a chip. The invention further provides method of fabricating hOR17-4 olfactory receptor.
Opening claim text (preview).
What is claimed is: 1. A bio-sensing nanodevice comprising: a stabilized biologically-derived G-protein coupled olfactory receptor-immobilized on a support, a real time receptor-ligand binding detection system method, a test composition delivery system and a test composition recognition program, wherein the stabilized receptor is stabilized with surfactant peptides selected from the group consisting of: Sequence (N → C) Formula (φ) m (+) n 1 (+) n (φ) m 2 (φ) m (−) n 3 (−) n (φ) m 4 (−) n (φ) m (−) n 5 (+) n (φ) m (+) n 6 (φ) m (−)n(φ) m 7 (φ) m (+)n(φ) m 8 (+) n (φ) m (−) n 9 (−) n (φ) m (+) n 10 wherein: (Φ) represents independently for each occurrence a natural or non-natural amino acid comprising a hydrophobic sidechain; (+) represents independently for each occurrence a natural or non-natural amino acid comprising a sidechain that is cationic at physiological pH; (−) represents independently for each occurrence a natural or non-natural amino acid comprising a sidechain that is anionic at physiological pH; wherein the terminal amino acids are optionally substituted; m for each occurrence represents an integer greater than or equal to 5; and n for each occurrence represents an integer greater than or equal to 1; wherein the test composition delivery system is a microfluidic bubble logic operation. 2. The bio-sensing nanodevice of claim 1 , wherein the microfluidic bubble logic operation comprises microfluidic channels adapted for receiving micron-sized droplets and bubbles comprising a test composition.
G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH · CPC title
Apparatus specially adapted for solid-phase testing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.